What we do?

Phase 1 – Our primary mandate is to provide massively cost-subsidized Whole Genome Sequencing and analytics services for patients suffering from Undiagnosed Disease.

Phase 2 – We will extend the above disease area in a gated and phased manner to include Rare Genetic disorders.

Phase 3 – Eventually we will address other disease areas including Oncology, Common diseases, etc.

How will we do this?

We will partner with existing Service Providers in the Genomics Eco-system to access “patient-consented” clinical data including “Whole Genome Sequence (WGS)” information for Trios.

We will run a case-customized Bio-informatics pipeline (personalized genomics) for the Trio and generate a report.

We will work with the consulting clinician to interpret and communicate the report to patients.

We will provide periodic updates and guidance to work with our partner networks and to provide access to updated status information on disease and therapeutic progress.

What do we plan to achieve?

• Cost-de-limited access to Genomic Diagnostic checks
• Establish India-specific Guidance for Diagnostic prescription.
• Establish Clinical Report generating Computational platform.
• Establish a de-facto disease database for the Indian population.
• Fuel Genomic Diagnostic growth in India to become SOC.
• Encourage innovation in Public Health initiatives.